On June 13, 2019, Valisure announced the detections of N, N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and the International Association for Research of Cancer (“IARC”).

Complete Valisure Citizen Petition Documents: Full Petition

‍

Media Highlights:

• Becker’s Hospital Review: 4th carcinogen detected in common heart drug
• Bloomberg: Fourth Carcinogen Discovered in Heart Pills Used by Millions
• CBS News: Another cancer-causing chemical found in widely used blood-pressure pills
• CNBC: Pharmacy warns FDA of cancer-causing chemical found in widely used heart pill
• Fortune: Another Controversial Chemical Found in Popular Blood Pressure Medication
• Fierce Pharma: Pharmacy takes FDA to task in citizen petition over tainted valsartan
• The People’s Pharmacy: A New Carcinogen DMF Discovered in Valsartan BP Pills
• Physicians Weekly: Online pharmacy flags possible new impurity in blood pressure drug
• Reuters: Online pharmacy flags possible new impurity in blood pressure drug

‍